ACIU
Price
$1.62
Change
-$0.06 (-3.57%)
Updated
May 12, 04:59 PM (EDT)
Capitalization
168.69M
85 days until earnings call
JAZZ
Price
$103.59
Change
+$5.81 (+5.94%)
Updated
May 12, 04:59 PM (EDT)
Capitalization
6.38B
79 days until earnings call
Ad is loading...

ACIU vs JAZZ

Header iconACIU vs JAZZ Comparison
Open Charts ACIU vs JAZZBanner chart's image
AC Immune SA
Price$1.62
Change-$0.06 (-3.57%)
Volume$700
Capitalization168.69M
Jazz Pharmaceuticals
Price$103.59
Change+$5.81 (+5.94%)
Volume$42.57K
Capitalization6.38B
ACIU vs JAZZ Comparison Chart
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. JAZZ commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and JAZZ is a Buy.

Ad is loading...
COMPARISON
Comparison
May 13, 2025
Stock price -- (ACIU: $1.63 vs. JAZZ: $103.58)
Brand notoriety: ACIU and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 119% vs. JAZZ: 117%
Market capitalization -- ACIU: $168.69M vs. JAZZ: $6.38B
ACIU [@Biotechnology] is valued at $168.69M. JAZZ’s [@Biotechnology] market capitalization is $6.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACIU and JAZZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 4 TA indicator(s) are bullish while JAZZ’s TA Score has 3 bullish TA indicator(s).

  • ACIU’s TA Score: 4 bullish, 4 bearish.
  • JAZZ’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACIU is a better buy in the short-term than JAZZ.

Price Growth

ACIU (@Biotechnology) experienced а -4.68% price change this week, while JAZZ (@Biotechnology) price change was -12.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.48%. For the same industry, the average monthly price growth was +10.12%, and the average quarterly price growth was -9.68%.

Reported Earning Dates

ACIU is expected to report earnings on Aug 06, 2025.

JAZZ is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-3.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($6.38B) has a higher market cap than ACIU($169M). JAZZ YTD gains are higher at: -20.601 vs. ACIU (-39.630). JAZZ has higher annual earnings (EBITDA): 1.25B vs. ACIU (-49.71M). JAZZ has more cash in the bank: 2.57B vs. ACIU (146M). ACIU has less debt than JAZZ: ACIU (5.18M) vs JAZZ (5.42B). JAZZ has higher revenues than ACIU: JAZZ (4.07B) vs ACIU (28.3M).
ACIUJAZZACIU / JAZZ
Capitalization169M6.38B3%
EBITDA-49.71M1.25B-4%
Gain YTD-39.630-20.601192%
P/E RatioN/A13.29-
Revenue28.3M4.07B1%
Total Cash146M2.57B6%
Total Debt5.18M5.42B0%
FUNDAMENTALS RATINGS
ACIU vs JAZZ: Fundamental Ratings
ACIU
JAZZ
OUTLOOK RATING
1..100
399
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9460
PRICE GROWTH RATING
1..100
6482
P/E GROWTH RATING
1..100
8292
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACIU's Valuation (53) in the Pharmaceuticals Major industry is in the same range as JAZZ (58) in the Pharmaceuticals Other industry. This means that ACIU’s stock grew similarly to JAZZ’s over the last 12 months.

ACIU's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as JAZZ (100) in the Pharmaceuticals Other industry. This means that ACIU’s stock grew similarly to JAZZ’s over the last 12 months.

JAZZ's SMR Rating (60) in the Pharmaceuticals Other industry is somewhat better than the same rating for ACIU (94) in the Pharmaceuticals Major industry. This means that JAZZ’s stock grew somewhat faster than ACIU’s over the last 12 months.

ACIU's Price Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as JAZZ (82) in the Pharmaceuticals Other industry. This means that ACIU’s stock grew similarly to JAZZ’s over the last 12 months.

ACIU's P/E Growth Rating (82) in the Pharmaceuticals Major industry is in the same range as JAZZ (92) in the Pharmaceuticals Other industry. This means that ACIU’s stock grew similarly to JAZZ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUJAZZ
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
58%
MACD
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
60%
Advances
ODDS (%)
Bullish Trend 19 days ago
73%
Bullish Trend 11 days ago
62%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
53%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
58%
View a ticker or compare two or three
Ad is loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNLCX49.02N/A
N/A
BNY Mellon Active MidCap C
JNGLX63.81N/A
N/A
Janus Henderson Global Life Sciences D
FISVX23.37N/A
N/A
Fidelity Small Cap Value Index
FCEEX10.81N/A
N/A
Franklin Emerging Market Core Equity Adv
EEMPX8.43N/A
N/A
MFS Emerging Markets Equity Research A

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with AMLX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
-0.64%
AMLX - JAZZ
43%
Loosely correlated
+0.66%
FTRE - JAZZ
38%
Loosely correlated
+3.36%
TECH - JAZZ
36%
Loosely correlated
+0.32%
SRPT - JAZZ
35%
Loosely correlated
-0.68%
REGN - JAZZ
34%
Loosely correlated
-3.63%
More